Price Alert

Inovio Pharmaceuticals In... (INO)

NASDAQ: INO · Real-Time Price · USD

2.75

0.04 (1.48%)

At close: Sep 04, 2025, 3:59 PM

2.71

-1.45%

After-hours: Sep 04, 2025, 07:40 PM EDT

1.48% (1D)

Bid	2.71
Market Cap	146.14M
Revenue (ttm)	182.34K
Net Income (ttm)	-44.9B
EPS (ttm)	-2.59
PE Ratio (ttm)	-1.06
Forward PE	-1.7
Analyst	Buy

Ask	2.79
Volume	1,726,161
Avg. Volume (20D)	2,227,477
Open	2.75
Previous Close	2.71
Day's Range	2.61 - 2.79
52-Week Range	1.30 - 7.00
Beta	1.39

About INO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol INO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for INO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Inovio Pharmaceuticals Inc. is scheduled to release its earnings on Nov 13, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-37.85%

Inovio Pharmaceuticals shares are trading lower af... Unlock content with Pro Subscription

2 months ago

+4.9%

Inovio shares are trading lower after the company announced a proposed public offering.

News

1 week ago · zacks.com

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

Inovio stock surges 21% after the FDA gives green light to begin a rolling BLA for its RRP drug INO-3107, with plans to seek priority review.

3 weeks ago · seekingalpha.com

Inovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call Transcript

Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Jacqueline E. Shea - CEO, President & Director Jennie Willson - Corporate Pa...

3 weeks ago · zacks.com

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.

1 month ago · zacks.com

Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?

Inovio (INO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.